Meet the founder
Dr Anna
McLaughlin
Neuroscientist & Founder
PhD in Neuroscience & Psychology from King’s College London.
.png)
I’m Anna, and I founded Sci-translate to empower people with the knowledge to become happier and healthier.
I have a PhD in Neuroscience & Psychology and Masters in Psychiatric Research from King's College London. I've also published many academic papers in peer-reviewed journals, and a book chapter with Oxford University Press.
Surprisingly, I didn’t start out wanting to be a scientist. I initially studied graphic design and illustration. But my curiosity about human behaviour led me to psychology, where I became fascinated by what drives people's actions and desires. Eventually, this turned into studying psychiatry, epidemiology, neuroscience, and even immunology!
During my PhD, I saw the incredible ways that science and technology could improve lives and address healthcare issues. However, I also noticed that much of our academic knowledge wasn’t reaching the public. Many preventable health conditions were simply due to a lack of accessible information and tools.
I founded Sci-translate to bridge this gap, helping businesses use science to improve health and well-being.
Since then, Sci-translate has assisted businesses and charities in creating credible content and developing science-backed products, resulting in more effective and personalised care.
My journey from art to science taught me the power of creativity and how it can transform passive learning into an active experience. By combining science with creativity, I believe we can make health information exciting, accessible, and inclusive for everyone.
Helping you translate science into actionable solutions, one breakthrough at a time.
PhD in Neuroscience & Psychology from King’s College London
MSc in Psychiatric Research & BSc in Psychological Science
Featured in the Financial Times within one month of founding Sci-translate
Published multiple peer-reviewed academic journals and a book chapter with Oxford University Press
Awarded the Public Communication Prize by the British Association of Psychopharmacology
Testimonials
Anna and the Sci-translate team were a joy to work with! They helped us validate our neurodiversity tool within a tight timeline and made complex findings easy for our team to understand. Thanks to their connections, we were able to set up a clinical partnership smoothly, which really boosted our credibility.
Ai Ling Walker
Founder of Noetic
Sci-translate made the process very easy, and the final product captures my professional essence really well. I have been approached by a couple of media outlets for my views so the work is clearly appealing and professional. I would definitely recommend your services to others - a very professional user experience - thank you!
Salma Ali
Specialist Pharmacist
Sci-translate's work was instrumental in establishing my professional identity. Your team captured everything with remarkable accuracy and depth. I would recommend your services for their thoroughness and insight. Thank you for your patience and understanding!
Paul Lefever
Director & International Executive Mental Health Case Manager
Sci-translate broke down the complex topic beautifully, making it highly relevant to our industry. The visual simplicity of the presentation was also a standout, providing an engaging and pleasant experience throughout the session. It’s rare to find such a tailored approach that didn’t require extensive back-and-forth to meet our needs.
Megan Freimann
Senior Account Manager at Levellr
.svg)
2023
Cambridge University Press: Peripheral inflammation associated with depression and reduced weight loss
2023
Psychoneuroendocrinology: Disentangling the effects of depression and perceived stress on cortisol levels in individuals with obesity
2022
Psychological Medicine: The influence of comorbid depression and overweight status on peripheral inflammation and cortisol levels
2022
Brain, Behavior, & Immunity-Health: Sex differences in a double-blind randomized clinical trial with minocycline in treatment-resistant depressed patients
2022
Schizophrenia Research: Relationship between cortical glutamatergic metabolite levels and hippocampal activity in schizotypy
2021
Psychoneuroendocrinology: Inflammation-related mRNA gene expression absolute levels are associated with treatment-resistant depression in the BIODEP study
2021
Biological Psychiatry: A Modest Increase in 11C-PK11195-Positron Emission Tomography TSPO Binding in Depression Is Not Associated With Serum C-Reactive Protein or Body Mass Index
2021
Neuropsychopharmacology: Augmentation therapy with minocycline in treatment-resistant depression patients with low-grade peripheral inflammation: results from a double-blind randomised clinical trial
2021
Psychoneuroendocrinology: An investigation into the role of childhood trauma and inflammatory profiles in depression
2021
Psychoneuroendocrinology: Disentangling the effects of depression and perceived stress on cortisol levels in individuals with obesity
2021
Psychoneuroendocrinology: Sex differences in a double-blind randomized clinical trial with minocycline: pilot findings on the key role of the immune system in treatment-resistant depressed female patients
2020
Brain, Behavior, & Immunity: Childhood trauma, HPA axis activity and antidepressant response in patients with depression
2020
Translational Psychiatry: Whole-blood expression of inflammasome- and glucocorticoid-related mRNAs correctly separates treatment-resistant depressed patients from drug-free and responsive patients
2018
Human Brain Mapping: Increased resting perfusion of the hippocampus in high positive schizotypy: A pseudocontinuous arterial spin labeling study
2018
Psychological Medicine: Neuroanatomical changes in people with high schizotypy: relationship to glutamate levels
2017
Translational Psychiatry: Corticolimbic hyper-response to emotion and glutamatergic function in people with high schizotypy: a multimodal fMRI-MRS study
.svg)